18.07.2025 • Topics

ISPE Good Practice Guide: Validation 4.0

The Validation 4.0 Guide provides a comprehensive approach to ensuring product quality and patient safety throughout a pharmaceutical product's lifecycle. A Holistic Control Strategy (HCS) in this context means moving beyond traditional, static, upfront and localized validation controls to a dynamic, data-driven, and continuous approach to managing risks and quality along the broader value chain.

Guide cover
© ISPE

This Guide is intended to be an early introduction into modern validation thinking in an increasingly digital world that offers new capabilities for managing and controlling manufacturing processes. The structure starts with an overview of methodology considerations, covers foundational enablers, required capabilities and a section on real-life case studies that have been selected to explain aspects to consider when adopting Validation 4.0 in practice.

A Maturity Self-Assessment Tool is included in the E-Reader (under Materials/Supplements) as a downloadable Microsoft Excel file to purchasers of the Guide. See the FAQ for accessing instructions.

The primary intention behind this self-assessment tool is to empower organizations to accurately characterize their current state of maturity and, more importantly, identify specific areas where targeted improvements can be made.

ISPE Good Practice Guide: Validation 4.0

Click here to purchase the guide.

Access Here!

Company

Logo:

International Society for Pharmaceutical Engineering (ISPE)

6110 Executive Blvd.
20852 North Bethesda
US

Company contact







From Catalogue to Collaboration

Enamine's Expert Insights Collection Is Free to Download
Enamine’s 35 Years of Advancing Drug Discovery

Enamine's Expert Insights Collection Is Free to Download

From catalogue to collaboration — explore 35 years of drug discovery breakthroughs, novel building blocks, and the science shaping tomorrow's medicines. Download your complimentary copy now.

Article

The State of the US Specialty Chemicals Industry
Reshaping Specialty Chemicals Manufacturing

The State of the US Specialty Chemicals Industry

SOCMA's Jenn Klein examines how specialty chemical manufacturers — the invisible backbone behind pharmaceuticals, electronics, agriculture, and energy — are navigating supply chain shifts, policy uncertainty, and constant change while remaining resilient, disciplined, and focused on execution.

most read